0001895948-21-000002.txt : 20211202
0001895948-21-000002.hdr.sgml : 20211202
20211202152148
ACCESSION NUMBER: 0001895948-21-000002
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211201
FILED AS OF DATE: 20211202
DATE AS OF CHANGE: 20211202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scripture Charity
CENTRAL INDEX KEY: 0001895948
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36783
FILM NUMBER: 211466298
MAIL ADDRESS:
STREET 1: C/O BELLICUM PHARMACEUTICALS, INC.
STREET 2: 3730 KIRBY DRIVE, STE. 1200
CITY: HOUSTON
STATE: TX
ZIP: 77098
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001358403
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201450200
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3730 KIRBY DRIVE
STREET 2: SUITE 1200
CITY: HOUSTON
STATE: TX
ZIP: 77098
BUSINESS PHONE: (832) 384-1100
MAIL ADDRESS:
STREET 1: 3730 KIRBY DRIVE
STREET 2: SUITE 1200
CITY: HOUSTON
STATE: TX
ZIP: 77098
FORMER COMPANY:
FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060405
3
1
wf-form3_163847649646886.xml
FORM 3
X0206
3
2021-12-01
0
0001358403
BELLICUM PHARMACEUTICALS, INC
BLCM
0001895948
Scripture Charity
C/O BELLICUM PHARMACEUTICALS, INC.
3730 KIRBY DRIVE, SUITE 1200
HOUSTON
TX
77098
0
1
0
0
Chief Development Officer
Common Stock
14587
D
Stock Option (right to buy)
4.41
2028-11-01
Common Stock
2500.0
D
Stock Option (right to buy)
1.36
2030-02-02
Common Stock
19300.0
D
Stock Option (right to buy)
7.13
2030-08-02
Common Stock
20000.0
D
Stock Option (right to buy)
2.97
2030-12-14
Common Stock
35000.0
D
Stock Option (right to buy)
2.88
2031-08-16
Common Stock
50000.0
D
25% of the shares subject to the stock option vest and became exercisable on October 1, 2019, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
25% of the shares subject to the stock option vest and became exercisable on February 3, 2021, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
100% of the shares subject to the stock option vest and became exercisable on August 3, 2021.
50% of the shares subject to the stock option vest and become exercisable on December 15, 2021, and the remaining shares subject to the stock option vest and become exercisable in 12 equal monthly installments thereafter.
50% of the shares subject to the stock option vest and become exercisable on August 16, 2022, and the remaining shares subject to the stock option vest and become exercisable in 12 equal monthly installments thereafter.
Charity Scripture
2021-12-02